| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(19)30956-0 |
| P698 | PubMed publication ID | 31178151 |
| P50 | author | Jun Ma | Q50066716 |
| Anthony Tak-Cheung Chan | Q57615001 | ||
| Ying Sun | Q68691886 | ||
| Yu-Pei Chen | Q85922141 | ||
| P2093 | author name string | Quynh-Thu Le | |
| Pierre Blanchard | |||
| P2860 | cites work | A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci | Q28943422 |
| A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma | Q28943472 | ||
| Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer | Q29615679 | ||
| Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy | Q30798219 | ||
| Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials | Q30980856 | ||
| What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis. | Q31146986 | ||
| Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial. | Q33434878 | ||
| Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan | Q33847952 | ||
| Tobacco consumption and genetic susceptibility to nasopharyngeal carcinoma (NPC) in Thailand | Q34453484 | ||
| Neoantigens in cancer immunotherapy. | Q34470074 | ||
| Radiomics: Images Are More than Pictures, They Are Data | Q34502075 | ||
| EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy | Q35067875 | ||
| Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China | Q35521697 | ||
| Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis | Q35752565 | ||
| Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system | Q36121121 | ||
| Chemoradiotherapy Versus Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: A Systemic Review and Meta-analysis of 2138 Patients | Q36292553 | ||
| A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry | Q36463672 | ||
| Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma | Q36742929 | ||
| An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma | Q36778016 | ||
| A new prognostic histopathologic classification of nasopharyngeal carcinoma | Q36871850 | ||
| Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. | Q37246505 | ||
| Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. | Q37323204 | ||
| Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience | Q37365740 | ||
| Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review | Q37503786 | ||
| Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy | Q37507369 | ||
| Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma | Q37526560 | ||
| Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy | Q37539740 | ||
| The battle against nasopharyngeal cancer | Q38039536 | ||
| Individualized treatment in stage IVC nasopharyngeal carcinoma. | Q38187333 | ||
| Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta-analysis and a systematic review of the literature | Q38302568 | ||
| Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis | Q38426149 | ||
| Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. | Q38583301 | ||
| Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-based Subtypes | Q38603137 | ||
| Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study | Q38610220 | ||
| Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis | Q38627668 | ||
| Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era. | Q38661169 | ||
| Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer. | Q38735125 | ||
| Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study | Q50084428 | ||
| Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy | Q50140800 | ||
| Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial. | Q50885004 | ||
| Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. | Q50947118 | ||
| Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. | Q50986703 | ||
| An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma. | Q51629770 | ||
| Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system. | Q51799440 | ||
| Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results. | Q52630953 | ||
| Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. | Q52675949 | ||
| Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma. | Q52718325 | ||
| The Immune Landscape of Cancer. | Q52720878 | ||
| Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect | Q38810615 | ||
| Genetic susceptibility to the endemic form of NPC. | Q38819362 | ||
| Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment | Q38846301 | ||
| Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site. | Q38851099 | ||
| Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma | Q38916435 | ||
| Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial | Q38943249 | ||
| The genomic landscape of nasopharyngeal carcinoma | Q38982367 | ||
| Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area | Q38993510 | ||
| Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. | Q39011183 | ||
| Metronomic chemotherapy and immunotherapy in cancer treatment | Q39131765 | ||
| Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types | Q39661584 | ||
| Global trends in incidence and mortality of nasopharyngeal carcinoma | Q40039321 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer. | Q40089200 | ||
| Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy | Q40180175 | ||
| Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area | Q40316145 | ||
| Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma | Q40402777 | ||
| Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial | Q40559922 | ||
| Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial | Q40633739 | ||
| Oral Hygiene and Risk of Nasopharyngeal Carcinoma-A Population-Based Case-Control Study in China | Q40667482 | ||
| New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system | Q40857402 | ||
| The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma. | Q41093379 | ||
| The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma. | Q41153419 | ||
| Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma | Q41221015 | ||
| Active and Passive Smoking and Risk of Nasopharyngeal Carcinoma: A Population-Based Case-Control Study in Southern China | Q41973121 | ||
| Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid | Q42225111 | ||
| Plasma Epstein-Barr viral DNA load at midpoint of radiotherapy course predicts outcome in advanced-stage nasopharyngeal carcinoma. | Q42230815 | ||
| Etiological factors of nasopharyngeal carcinoma | Q42231417 | ||
| Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma | Q42969004 | ||
| Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions | Q43920062 | ||
| Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie | Q44047357 | ||
| Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival | Q44315391 | ||
| Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study | Q44958698 | ||
| Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels | Q45354343 | ||
| International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. | Q46143595 | ||
| Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma | Q46274566 | ||
| Nasopharyngeal carcinoma incidence and mortality in China, 2013. | Q46503743 | ||
| Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy | Q47124202 | ||
| Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy | Q47187805 | ||
| Long-term outcomes after reirradiation in nasopharyngeal carcinoma with intensity-modulated radiotherapy: A meta-analysis. | Q47609586 | ||
| Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma | Q47844082 | ||
| Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients | Q48005681 | ||
| Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma. | Q48042302 | ||
| Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study. | Q48152319 | ||
| Multi-subject atlas-based auto-segmentation reduces interobserver variation and improves dosimetric parameter consistency for organs at risk in nasopharyngeal carcinoma: A multi-institution clinical study | Q48153822 | ||
| Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. | Q48173597 | ||
| Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma | Q48527904 | ||
| Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials | Q50066646 | ||
| Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up. | Q53363369 | ||
| How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? | Q53418960 | ||
| Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiother | Q53662723 | ||
| A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02). | Q53709897 | ||
| Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. | Q53826386 | ||
| Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes. | Q54748161 | ||
| Salvage surgery for nasopharyngeal cancer. | Q55182779 | ||
| Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma | Q57077756 | ||
| Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection | Q57458964 | ||
| The use of MR imaging to detect residual versus recurrent nasopharyngeal carcinoma following treatment with radiation therapy | Q57516354 | ||
| Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma | Q57796235 | ||
| Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy | Q58574577 | ||
| A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma | Q58876646 | ||
| Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials | Q58876649 | ||
| The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma | Q59344265 | ||
| Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis | Q59349775 | ||
| Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742) | Q59350023 | ||
| Value of early evaluation of treatment response using F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma | Q59351734 | ||
| The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification | Q59353133 | ||
| Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment | Q59360963 | ||
| Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma | Q59647312 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy | Q61445797 | ||
| Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 | Q74463750 | ||
| Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality | Q78696424 | ||
| Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial | Q79404716 | ||
| To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area | Q82221005 | ||
| Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial | Q82364367 | ||
| Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma | Q83387461 | ||
| Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Grou | Q83985307 | ||
| Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma | Q84346964 | ||
| A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma | Q85005668 | ||
| Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy | Q85782703 | ||
| Nasopharyngeal carcinoma | Q86035551 | ||
| Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma | Q86756671 | ||
| Intensity-modulated proton therapy for nasopharyngeal carcinoma: Decreased radiation dose to normal structures and encouraging clinical outcomes | Q86976274 | ||
| Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma | Q87543924 | ||
| Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma | Q87749994 | ||
| Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma | Q87951509 | ||
| NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018 | Q88645684 | ||
| Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group | Q90281730 | ||
| Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial | Q90913239 | ||
| Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials | Q91433225 | ||
| Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma | Q92624706 | ||
| P433 | issue | 10192 | |
| P304 | page(s) | 64-80 | |
| P577 | publication date | 2019-06-06 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Nasopharyngeal carcinoma | |
| P478 | volume | 394 |
| Q89798467 | A novel Epstein-Barr virus subtype associated with nasopharyngeal carcinoma found in South China |
| Q94564490 | ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma |
| Q97530172 | AR-induced long non-coding RNA LINC01503 facilitates proliferation and metastasis via the SFPQ-FOSL1 axis in nasopharyngeal carcinoma |
| Q90128398 | Advances in nasopharyngeal carcinoma-"West meets East" |
| Q100945769 | Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| Q112278320 | Analysis of the Molecular Mechanism of Evodia rutaecarpa Fruit in the Treatment of Nasopharyngeal Carcinoma Using Network Pharmacology and Molecular Docking |
| Q93006259 | Asiatic Acid, Extracted from Centella asiatica and Induces Apoptosis Pathway through the Phosphorylation p38 Mitogen-Activated Protein Kinase in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells |
| Q90753119 | Association between coarse particulate matter (PM10-2.5) and nasopharyngeal carcinoma among Taiwanese men |
| Q90309065 | Association of Ambient Air Pollution with Nasopharyngeal Carcinoma Incidence in Ten Large Chinese Cities, 2006-2013 |
| Q95273461 | Carcinoma of unknown primary detected by whole-body diffusion-weighted imaging: A case report and review of the literature |
| Q90053638 | Chemoresistance Mediated by ceRNA Networks Associated With the PVT1 Locus |
| Q89727196 | Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1 |
| Q95276533 | Circular RNA Expression Profiles in Nasopharyngeal Carcinoma by Sequence Analysis |
| Q97570260 | Circular RNA Hsa_circ_0066755 as an Oncogene via sponging miR-651 and as a Promising Diagnostic Biomarker for Nasopharyngeal Carcinoma |
| Q90187382 | Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma |
| Q99632293 | Clinicopathological Characteristics and Prognosis of Nasopharyngeal Lymphoepithelial Carcinoma: A Population-Based Retrospective Study |
| Q94495456 | Comparing Long-Term Survival and Late Toxicities of Different Sequential Chemotherapy Regimens with Intensity-Modulated Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma |
| Q99559823 | Comparison of diagnostic accuracy of computed tomography virtual endoscopy and flexible fibre-optic laryngoscopy in the evaluation of neck anatomic structures and neoplasms |
| Q99629833 | Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis |
| Q91762477 | DNA methylation biomarkers for nasopharyngeal carcinoma |
| Q99566804 | Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma |
| Q112278295 | Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma |
| Q97423382 | Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p |
| Q92819792 | Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer |
| Q89883642 | Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis |
| Q90576977 | FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p |
| Q97681154 | Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3 |
| Q90698175 | Integrated analysis of transcriptome profiling predicts potential lncRNA and circRNA targets in human nasopharyngeal carcinoma |
| Q91713556 | Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients |
| Q99200160 | Life Beyond COVID: Pay Attention to Viruses |
| Q90669124 | Long Non-Coding RNA DLEU1 Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma |
| Q90217247 | Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China |
| Q89497700 | Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy |
| Q89908237 | Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review |
| Q94475235 | MicroRNA-21 depletion by CRISPR/Cas9 in CNE2 nasopharyngeal cells hinders proliferation and induces apoptosis by targeting the PI3K/AKT/MOTOR signaling pathway |
| Q90586120 | Optimizing number of cycles of induction chemotherapy for patients with nasopharyngeal carcinoma: Retrospective survival analysis |
| Q90217298 | Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience |
| Q99565265 | Outcomes and Experiences of Child-Bearing Women with Nasopharyngeal Carcinoma |
| Q99630290 | Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma |
| Q91828776 | Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma |
| Q104261662 | Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasophafryngeal carcinoma |
| Q98170174 | Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients |
| Q100558893 | RASSF1A inhibits PDGFB-driven malignant phenotypes of nasopharyngeal carcinoma cells in a YAP1-dependent manner |
| Q94554680 | Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21 |
| Q96576801 | S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1 |
| Q90079727 | SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells |
| Q97595758 | Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma |
| Q93272409 | Study on the chemodrug-induced effect in nasopharyngeal carcinoma cells using laser tweezer Raman spectroscopy |
| Q90410019 | TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition |
| Q94550209 | TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple |
| Q92067727 | TSPAN8 and distant metastasis of nasopharyngeal carcinoma cells |
| Q96304633 | Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma |
| Q89519663 | The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma |
| Q104500571 | The effect of adding concurrent chemotherapy to radiotherapy for stage II nasopharyngeal carcinoma with undetectable pretreatment Epstein-Barr virus DNA: Retrospective analysis with a large institutional-based cohort |
| Q92823784 | Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015 |
| Q90640852 | Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation |
| Q95849513 | Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1 |
| Q98771162 | m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis |
| Q92068511 | miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP |
Search more.